Olympus had one patents in 3D printing during Q4 2023. The patent filed by Olympus Corp in Q4 2023 relates to devices designed for insertion into curved or tortuous paths, with axial support components for forward movement and lateral support components for limiting lateral motion. GlobalData’s report on Olympus gives a 360-degreee view of the company including its patenting strategy. Buy the report here.
Olympus grant share with 3D printing as a theme is 0% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Flexible and/or pushable tubular device (Patent ID: US20230355928A1)
The patent filed by Olympus Corp. describes a medical device designed for insertion into a curved or tortuous path. The device includes axial support components that can rock and tilt in different directions, along with lateral support components to limit lateral movement. The tubular member of the device comprises stacked axial support components and lateral support components to facilitate movement through the path.
The device includes a plurality of axial support components arranged in a stacked manner, with each component capable of rocking and tilting. The lateral support components reduce lateral movement between adjacent axial support components. Additionally, the device may include control components for controlling the direction of bending at the proximal end of the tubular member. The design allows for flexibility and adaptability to navigate through complex paths with ease, making it suitable for medical procedures requiring precise and controlled movement within cavities or openings.
To know more about GlobalData’s detailed insights on Olympus, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.